Author:
Rahimi Roja,Nikfar Shekoufeh,Rezaie Ali,Abdollahi Mohammad
Publisher
Springer Science and Business Media LLC
Subject
Gastroenterology,Physiology
Reference26 articles.
1. Shen EH, Das KM (2004) Current therapeutic recommendations: infliximab for ulcerative colitis. J Clin Gastroenterol 38:741–745. doi: 10.1097/01.mcg.0000140188.88275.65
2. Kucharzik T, Maaser C, Lügering A, Kagnoff M, Mayer L, Targan S et al (2006) Recent understanding of IBD pathogenesis: implications for future therapies. Inflamm Bowel Dis 12:1068–1083. doi: 10.1097/01.mib.0000235827.21778.d5
3. Rezaie A, Khalaj S, Shabihkhani M, Nikfar S, Zamani MJ, Mohammadirad A et al (2007) Study on the correlations among disease activity index and salivary transforming growth factor-β1 and nitric oxide in ulcerative colitis patients. Ann N Y Acad Sci 1095:305–314. doi: 10.1196/annals.1397.034
4. Rahimi R, Nikfar S, Abdollahi A (2007) Meta analysis technique confirms the effectiveness of anti-TNFa in the management of active ulcerative colitis when administered in combination with corticosteroids. Med Sci Monit 13:PI13–PI18
5. Rahimi R, Nikfar S, Abdollahi M (2007) Do anti tumor necrosis factors induce response and remission in patients with acute refractory Crohn’s disease? A meta-analysis of controlled clinical trials. Biomed Pharmacother 61:75–80. doi: 10.1016/j.biopha.2006.06.022
Cited by
36 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献